Osiris Therapeutics Inc. (NASDAQ:OSIR) shares shot up 4.1% on Thursday . The stock traded as high as $5.35 and last traded at $5.28, with a volume of 58,053 shares. The stock had previously closed at $5.07.

The firm has a market capitalization of $188.45 million and a price-to-earnings ratio of 130.24. The firm has a 50-day moving average of $5.14 and a 200-day moving average of $5.68.

A hedge fund recently raised its stake in Osiris Therapeutics stock. GSA Capital Partners LLP boosted its stake in Osiris Therapeutics Inc. (NASDAQ:OSIR) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 98,901 shares of the company’s stock after buying an additional 9,702 shares during the period. GSA Capital Partners LLP owned 0.29% of Osiris Therapeutics worth $1,027,000 as of its most recent SEC filing.

Osiris Therapeutics, Inc is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company’s offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and Grafix.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.